417 related articles for article (PubMed ID: 23299308)
41. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
Galli G; Nuti S; Tavarini S; Galli-Stampino L; De Lalla C; Casorati G; Dellabona P; Abrignani S
J Exp Med; 2003 Apr; 197(8):1051-7. PubMed ID: 12695492
[TBL] [Abstract][Full Text] [Related]
42. Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant.
Li X; Fujio M; Imamura M; Wu D; Vasan S; Wong CH; Ho DD; Tsuji M
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13010-5. PubMed ID: 20616071
[TBL] [Abstract][Full Text] [Related]
43. Hepatocellular cancer-derived alpha fetoprotein uptake reduces CD1 molecules on monocyte-derived dendritic cells.
Li C; Song B; Santos PM; Butterfield LH
Cell Immunol; 2019 Jan; 335():59-67. PubMed ID: 30392891
[TBL] [Abstract][Full Text] [Related]
44. A Subset of CD8αβ+ Invariant NKT Cells in a Humanized Mouse Model.
Wen X; Kim S; Xiong R; Li M; Lawrenczyk A; Huang X; Chen SY; Rao P; Besra GS; Dellabona P; Casorati G; Porcelli SA; Akbari O; Exley MA; Yuan W
J Immunol; 2015 Aug; 195(4):1459-69. PubMed ID: 26157173
[TBL] [Abstract][Full Text] [Related]
45. Differential contribution of dendritic cell CD1d to NKT cell-enhanced humoral immunity and CD8+ T cell activation.
Joshi SK; Lang GA; Devera TS; Johnson AM; Kovats S; Lang ML
J Leukoc Biol; 2012 May; 91(5):783-90. PubMed ID: 22331103
[TBL] [Abstract][Full Text] [Related]
46. NKT and tolerance.
Diana J; Beaudoin L; Gautron AS; Lehuen A
Methods Mol Biol; 2011; 677():193-206. PubMed ID: 20941612
[TBL] [Abstract][Full Text] [Related]
47. Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses.
Webb TJ; Carey GB; East JE; Sun W; Bollino DR; Kimball AS; Brutkiewicz RR
Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27297969
[TBL] [Abstract][Full Text] [Related]
48. Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma.
Wu L; Yun Z; Tagawa T; De la Maza L; Wu MO; Yu J; Zhao Y; de Perrot M
Cancer Immunol Immunother; 2014 Dec; 63(12):1285-96. PubMed ID: 25183171
[TBL] [Abstract][Full Text] [Related]
49. Anti-Vα24Jα18 TCR Antibody Tunes iNKT Cell Responses to Target and Kill CD1d-negative Tumors in an FcγRII (CD32)-dependent Manner.
Takami M; Aoki T; Nishimura K; Tanaka H; Onodera A; Motohashi S
Cancer Res Commun; 2024 Feb; 4(2):446-459. PubMed ID: 38319156
[TBL] [Abstract][Full Text] [Related]
50. Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy.
Wu TN; Lin KH; Chang YJ; Huang JR; Cheng JY; Yu AL; Wong CH
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17275-80. PubMed ID: 21987790
[TBL] [Abstract][Full Text] [Related]
51. The effect of intracellular trafficking of CD1d on the formation of TCR repertoire of NKT cells.
Shin JH; Park SH
BMB Rep; 2014 May; 47(5):241-8. PubMed ID: 24755556
[TBL] [Abstract][Full Text] [Related]
52. Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity.
Cohen NR; Garg S; Brenner MB
Adv Immunol; 2009; 102():1-94. PubMed ID: 19477319
[TBL] [Abstract][Full Text] [Related]
53. Human and mouse type I natural killer T cell antigen receptors exhibit different fine specificities for CD1d-antigen complex.
Wun KS; Ross F; Patel O; Besra GS; Porcelli SA; Richardson SK; Keshipeddy S; Howell AR; Godfrey DI; Rossjohn J
J Biol Chem; 2012 Nov; 287(46):39139-48. PubMed ID: 22995911
[TBL] [Abstract][Full Text] [Related]
54. Ox-LDL-induced CD80
Wang Y; Zou Y; Jiang Q; Li W; Chai X; Zhao T; Liu S; Yuan Z; Yu C; Wang T
Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1563-C1572. PubMed ID: 38586879
[TBL] [Abstract][Full Text] [Related]
55. CD1d-unrestricted NKT cells are endowed with a hybrid function far superior than that of iNKT cells.
Farr AR; Wu W; Choi B; Cavalcoli JD; Laouar Y
Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12841-6. PubMed ID: 25143585
[TBL] [Abstract][Full Text] [Related]
56. NKT TCR recognition of CD1d-α-C-galactosylceramide.
Patel O; Cameron G; Pellicci DG; Liu Z; Byun HS; Beddoe T; McCluskey J; Franck RW; Castaño AR; Harrak Y; Llebaria A; Bittman R; Porcelli SA; Godfrey DI; Rossjohn J
J Immunol; 2011 Nov; 187(9):4705-13. PubMed ID: 21964029
[TBL] [Abstract][Full Text] [Related]
57. Human Invariant Natural Killer T Cells Respond to Antigen-Presenting Cells Exposed to Lipids from Olea europaea Pollen.
Abos Gracia B; López Relaño J; Revilla A; Castro L; Villalba M; Martín Adrados B; Regueiro JR; Fernández-Malavé E; Martínez Naves E; Gómez Del Moral M
Int Arch Allergy Immunol; 2017; 173(1):12-22. PubMed ID: 28486236
[TBL] [Abstract][Full Text] [Related]
58. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
[TBL] [Abstract][Full Text] [Related]
59. NKT Cells Contribute to the Control of Microbial Infections.
Vogt S; Mattner J
Front Cell Infect Microbiol; 2021; 11():718350. PubMed ID: 34595131
[TBL] [Abstract][Full Text] [Related]
60. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
